Pmv Pharmaceuticals Inc (PMVP) Insider Trading
- $17,100,000.00
- $39,419,214.04
- Sept. 11, 2024
- Thilo Schroeder
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 11, 2024 | Insider | 7,218 | $1.50 | Sell | $10,827.00 | |
Sept. 11, 2024 | CFO | 2,891 | $1.50 | Sell | $4,336.50 | |
Nov. 22, 2023 | Major Shareholder | 87,786 | $2.23 | Sell | $195,762.78 | |
Sept. 15, 2023 | Insider | 4,104 | $6.62 | Sell | $27,168.48 | |
May 26, 2022 | Major Shareholder | 26,253 | $15.93 | Sell | $418,210.29 | |
March 31, 2022 | Major Shareholder | 34,500 | $21.17 | Sell | $730,365.00 | |
March 29, 2022 | Major Shareholder | 365,000 | $21.52 | Sell | $7,854,800.00 | |
Oct. 6, 2021 | Director | 800 | $30.15 | Sell | $24,120.00 | |
Oct. 4, 2021 | Director | 100 | $30.08 | Sell | $3,008.00 | |
Oct. 1, 2021 | Director | 11,541 | $30.10 | Sell | $347,384.10 | |
Sept. 29, 2021 | Director | 5,708 | $30.04 | Sell | $171,468.32 | |
Sept. 27, 2021 | Director | 1,753 | $30.11 | Sell | $52,782.83 | |
Sept. 22, 2021 | Director | 3,500 | $30.00 | Sell | $105,000.00 | |
Sept. 17, 2021 | Director | 711 | $30.03 | Sell | $21,351.33 | |
Sept. 13, 2021 | Director | 13,272 | $30.20 | Sell | $400,814.40 | |
Sept. 9, 2021 | Director | 14,329 | $30.31 | Sell | $434,311.99 | |
Sept. 7, 2021 | Insider | 3,900 | $30.25 | Sell | $117,975.00 | |
Sept. 1, 2021 | Director | 21,986 | $30.38 | Sell | $667,934.68 | |
Aug. 30, 2021 | Director | 13,233 | $30.05 | Sell | $397,651.65 | |
Aug. 27, 2021 | Director | 24,442 | $30.52 | Sell | $745,969.84 | |
Aug. 25, 2021 | Director | 13,526 | $31.01 | Sell | $419,441.26 | |
Aug. 23, 2021 | Director | 3,500 | $29.50 | Sell | $103,250.00 | |
Aug. 18, 2021 | Director | 26,864 | $33.34 | Sell | $895,645.76 | |
Aug. 16, 2021 | Director | 22,183 | $33.89 | Sell | $751,781.87 | |
Aug. 13, 2021 | Director | 27,286 | $34.24 | Sell | $934,272.64 | |
Aug. 11, 2021 | Director | 34,439 | $34.04 | Sell | $1,172,303.56 | |
Aug. 9, 2021 | Director | 22,182 | $35.53 | Sell | $788,126.46 | |
Aug. 9, 2021 | Insider | 4,471 | $34.04 | Sell | $152,192.84 | |
Aug. 6, 2021 | Director | 19,900 | $36.61 | Sell | $728,539.00 | |
Aug. 4, 2021 | Director | 52,860 | $35.85 | Sell | $1,895,031.00 | |
Aug. 3, 2021 | CFO | 4,500 | $33.82 | Sell | $152,190.00 | |
Aug. 2, 2021 | Director | 13,031 | $34.74 | Sell | $452,696.94 | |
July 28, 2021 | Director | 8,724 | $35.76 | Sell | $311,970.24 | |
July 26, 2021 | Director | 4,839 | $35.73 | Sell | $172,897.47 | |
July 22, 2021 | Director | 200 | $35.61 | Sell | $7,122.00 | |
July 20, 2021 | CEO | 1,029 | $35.53 | Sell | $36,560.37 | |
July 20, 2021 | Director | 3,500 | $35.12 | Sell | $122,920.00 | |
July 8, 2021 | CFO | 4,500 | $33.75 | Sell | $151,875.00 | |
July 7, 2021 | Insider | 4,000 | $32.30 | Sell | $129,200.00 | |
June 28, 2021 | CEO | 204 | $35.53 | Sell | $7,248.12 | |
June 21, 2021 | Director | 3,500 | $33.25 | Sell | $116,375.00 | |
June 14, 2021 | Major Shareholder | 44,419 | $34.11 | Sell | $1,515,132.09 | |
June 11, 2021 | Major Shareholder | 21,977 | $33.80 | Sell | $742,822.60 | |
June 9, 2021 | Major Shareholder | 39,638 | $33.64 | Sell | $1,333,422.32 | |
June 7, 2021 | Major Shareholder | 30,721 | $33.62 | Sell | $1,032,840.02 | |
June 7, 2021 | Insider | 4,000 | $33.60 | Sell | $134,400.00 | |
June 4, 2021 | CFO | 4,500 | $33.75 | Sell | $151,875.00 | |
June 1, 2021 | Director | 3,900 | $32.55 | Sell | $126,945.00 | |
May 28, 2021 | Director | 5,100 | $35.80 | Sell | $182,580.00 | |
May 26, 2021 | Director | 7,487 | $35.66 | Sell | $266,986.42 |
Insiders are both buying and selling Pmv Pharmaceuticals Inc stock.
The insider traders at Pmv Pharmaceuticals Inc are: Thilo Schroeder, Leila Alland, Orbimed Advisors Llc, Winston Kung, Euclidean Capital Llc, Arnold J Levine, David Henry Mack, Deepika Jalota, Arnold J. Levine, Michael Carulli, Ra Capital Management, L.P., and Richard A Heyman
The most active insider trader at Pmv Pharmaceuticals Inc is Thilo Schroeder with 35 trades.
Thilo Schroeder has sold the most Pmv Pharmaceuticals Inc stock with a total value of $23,200,568.66.
Ra Capital Management, L.P. has bought the most Pmv Pharmaceuticals Inc stock with a total value of $34,200,000.00.
The most recent insider trade for Pmv Pharmaceuticals Inc was on Sept. 11, 2024.
The single biggest insider buy for Pmv Pharmaceuticals Inc was from Ra Capital Management, L.P. with a total value of $17,100,000.00 on Sept. 29, 2020.
The single biggest insider sell for Pmv Pharmaceuticals Inc was from Orbimed Advisors Llc with a total value of $7,854,800.00 on March 29, 2022.